Copper-67 SAR-bisPSMA updates
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clarity Pharmaceuticals Ltd (CU6)Clarity Pharmaceuticals Ltd stock price live, this page displays ASX CU6 stock exchange data. View the CU6 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Clarity Pharmaceuticals Ltd real time stock price chart below.
What Is the Clarity Pharmaceuticals Ltd Stock Price Today?
The Clarity Pharmaceuticals Ltd stock price today is 5.520.
What Is the Stock Symbol for Clarity Pharmaceuticals Ltd?
The stock symbol for Clarity Pharmaceuticals Ltd is "CU6."
What Stock Exchange Does Clarity Pharmaceuticals Ltd Trade On?
Clarity Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Clarity Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Clarity Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CU6 quote. (ISIN: AU0000165375)
What Is the Clarity Pharmaceuticals Ltd Stock Price Today?
The Clarity Pharmaceuticals Ltd stock price today is 5.520.
What Is the Stock Symbol for Clarity Pharmaceuticals Ltd?
The stock symbol for Clarity Pharmaceuticals Ltd is "CU6."
What Stock Exchange Does Clarity Pharmaceuticals Ltd Trade On?
Clarity Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Clarity Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Clarity Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CU6 quote. (ISIN: AU0000165375)
Sydney
Currency in AUD
5.520
-0.090(-1.60%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.400
5.630
52 wk Range
1.595
8.975
CU6 Scorecard
Full Analysis
Stock has taken a big hit over the last week
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.4005.630
52 wk Range
1.5958.975
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
Book Value / Share
UnlockPrev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
Book Value / Share
UnlockCU6 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
8.893
Upside
+61.105%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price movements are quite volatile
Clarity Pharmaceuticals Ltd Company Profile
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States. The company’s products include SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2; developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. It develops theranostic therapy and imaging products for the treatment of cancer in children and adults. The company was incorporated in 2010 and is based in Sydney, Australia.
Compare CU6 to Peers and Sector
Metrics to compare | CU6 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCU6PeersSector | |
|---|---|---|---|---|
P/E Ratio | −41.8x | −1.8x | −0.7x | |
PEG Ratio | 0.66 | 0.00 | 0.00 | |
Price/Book | 12.1x | 4.8x | 2.6x | |
Price / LTM Sales | 153.6x | 7.3x | 3.2x | |
Upside (Analyst Target) | 53.6% | 110.9% | 46.6% | |
Fair Value Upside | Unlock | 18.4% | 7.4% | Unlock |
Analysts' Recommendations
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.893
(+61.11% Upside)
People Also Watch
FAQ
What Is the Clarity Pharmaceuticals (CU6) Stock Price Today?
The Clarity Pharmaceuticals stock price today is 5.52
What Stock Exchange Does Clarity Pharmaceuticals Trade On?
Clarity Pharmaceuticals is listed and trades on the Sydney stock exchange.
What Is the Stock Symbol for Clarity Pharmaceuticals?
The stock symbol for Clarity Pharmaceuticals is "CU6."
What Is the Clarity Pharmaceuticals Market Cap?
As of today, Clarity Pharmaceuticals market cap is 1.77B.
What is Clarity Pharmaceuticals Earnings Per Share?
The Clarity Pharmaceuticals EPS is -0.155.
From a Technical Analysis Perspective, Is CU6 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.